HIV Name Reporting and Partner Notification in New York State by Bhatnager, Sonia
Fordham Urban Law Journal
Volume 26 | Number 5 Article 9
1999
HIV Name Reporting and Partner Notification in
New York State
Sonia Bhatnager
Follow this and additional works at: https://ir.lawnet.fordham.edu/ulj
Part of the Health Law and Policy Commons
This Article is brought to you for free and open access by FLASH: The Fordham Law Archive of Scholarship and History. It has been accepted for
inclusion in Fordham Urban Law Journal by an authorized editor of FLASH: The Fordham Law Archive of Scholarship and History. For more
information, please contact tmelnick@law.fordham.edu.
Recommended Citation
Sonia Bhatnager, HIV Name Reporting and Partner Notification in New York State, 26 Fordham Urb. L.J. 1457 (1999).
Available at: https://ir.lawnet.fordham.edu/ulj/vol26/iss5/9
HIV NAME REPORTING AND PARTNER
NOTIFICATION IN NEW YORK STATE
Sonia Bhatnager*
Introduction
The World Health Organization estimates that new cases of full-
blown Acquired Immunodeficiency Syndrome ("AIDS")' increase
by almost twenty percent worldwide each year, and that at the end
of 1996, 1.64 million people worldwide were suffering from AIDS.2
It also estimates that only one-fifth of the actual number of cases is
reported.' The nature of the disease is changing as well: advance-
ments in drug therapy and treatment are enabling infected individ-
uals to remain asymptomatic for years.4
Calls for epidemiological data that enable scientists to study the
disease and treat people with HIV infection have led to HIV name
reporting in some states.5 Other states have instituted partner noti-
fication programs in hopes of apprising contacts of their exposure
* J.D. Candidate, Fordham University School of Law, 2000. B.A., History, Co-
lumbia College, Columbia University, 1997. The author would like to thank Professor
Elizabeth Cooper for her knowledgeable guidance, Alissa Brownrigg for her in-
sightful suggestions and Daniel S. Voloch for his selfless assistance. She would also
like to thank her family and friends for their continuous support and patience.
1. A case of AIDS was first defined as "illness in a person who 1) has either
biopsy-proven KS [Kaposi's Sarcoma] or biopsy- or culture-proven, life-threatening
opportunistic infection, 2) is under age 60, and 3) has no history of either immunosup-
pressive underlying illness or immunosuppressive therapy." U.S. Department of
Health and Human Services, Updates on Kaposi's Sarcoma and Opportunistic Infec-
tions in Previously Healthy Persons - United States, 31 MORBIDITY & MORTALITY
WKLY. REP. 294 (1982). The definition was expanded in 1985 to include diseases such
as disseminated histoplasmosis, chronic isosporiasis and certain non-Hodgkin's
lymphomas. In 1987, another expansion occurred to the definition, which resulted in
diseases such as extrapulmonary tuberculosis, HIV encephalopathy and HIV wasting
syndrome being added. The latest revision takes effect as of January 1, 1993, which
"includes all HIV-infected adults and adolescents who have less than [sic] 200 CD4+
T-lymphocytes/pL or a CD4+ T-lymphocyte percent of total lymphocytes less than 14,
or who have been diagnosed with pulmonary tuberculosis, invasive cervical cancer, or
recurrent pneumonia." Centers for Disease Control and Prevention, AIDS Surveil-
lance in the United States (visited Mar. 12, 1999) <http://www.cdc.gov> [hereinafter
CDC, AIDS Surveillance].
2. See AIDS Cases Rising Steadily Worldwide, TExAS HIV/STD UPDATE (Fall
1997) <http://www.tdh.state.tx.us/hivstd/up97fal.htm>.
3. See id.
4. See infra note 99 and accompanying text.
5. See The Association of the Bar of the City of New York (Committees on
AIDS, Civil Rights, Health Law, Legal Issues Affecting People with Disabilities and
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to the virus and breaking the chain of transmission.6 Thirty-three
states and U.S. Territories provide for some form of partner notifi-
cation by statute.7 Although, as of June 30, 1998, thirty-one states
collect the names of HIV-infected people,' these names only ac-
count for a small percent of those suffering from AIDS nationally.9
New York, on the other hand, has the nation's highest rate of re-
ported AIDS cases.10 Thus, New York's decision to enact a name
reporting and partner notification law may significantly influence
other states with high seroprevalence levels to follow its lead,1 or
alternatively, to determine that the process does not work in those
areas.
On July 7, 1998, the New York State Senate enacted a name re-
porting and partner notification law that amended Article 21 of the
Sex and Law), Name Reporting of HIV Cases 1, 1 (1998) [hereinafter NYC Bar, Name
Reporting].
6. See infra note 15 and accompanying text; see also Lawrence 0. Gostin &
James G. Hodge, Piercing the Veil of Secrecy in HIV/AIDS and Other Sexually Trans-
mitted Diseases: Theories of Privacy and Disclosure in Partner Notification, 5 DUKE J.
GENDER L. & POL'Y 9, 14 (1998) (claiming that the goal of contact tracing is to "re-
duce disease transmission by locating and containing the spread of a given STD within
a certain population") [hereinafter Gostin & Hodge, Piercing the Veil].
7. See The Association of the Bar of the City of New York (Committees on
AIDS, Civil Rights, Health Law, Mental Health, Legal Issues Affecting People with
Disabilities and Sex and Law), Partner Notification and HIV 1, 3 (1998) [hereinafter
NYC Bar, Partner Notification].
8. See Centers for Disease Control and Prevention, 10 HIV/AIDS SURVEIL-
LANCE REP. 1 (1998). Connecticut and Texas required name reporting of children less
than thirteen years old, and Oregon required reporting for children less than six years
of age. The remaining twenty-eight states that have laws requiring confidential re-
porting by name of all persons infected with HIV are Alabama, Arizona, Arkansas,
Colorado, Florida, Idaho, Indiana, Louisiana, Michigan, Minnesota, Mississippi, Mis-
souri, Nebraska, Nevada, New Jersey, New Mexico, North Carolina, North Dakota,
Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, Virginia, West Vir-
ginia, Wisconsin and Wyoming. See id. at 7. Texas disposed of its unique identifier
system and adopted name reporting for all HIV positive individuals as of January 1,
1999. See infra note 126 and accompanying text. New York also has adopted name
reporting for HIV as of July 1998. See infra notes 12-13 and accompanying text.
9. See NYC Bar, Name Reporting, supra note 5, at 1-2.
10. See Centers for Disease Control and Prevention, supra note 8, at 1. In a sur-
vey conducted from July 1997 to June 1998 of Metropolitan areas in the U.S., New
York City had the highest AIDS annual rate per 100,000 population with a rate of
101.2. No other city had a rate over 100.0 per 100,000. Jersey City, New Jersey came
the closest with a rate of 72.2 per 100,000. See id. at 8. More importantly, however, is
the fact that out of the 665,357 AIDS cases reported to the CDC through June 1998,
New York State contributed to about 124,793 of them. See id. at 6. The CDC does
not have HIV infection rates for New York. See id. at 5.
11. See Lynda Richardson, AIDS Groups Stunned by Vote for Partner Notification,
N.Y. TIMES, June 20, 1998, at B3.
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Public Health Law by adding a new Title 111.12 The new law re-
quires physicians and other health officials to report individuals
who test positive for HIV, AIDS or other HIV-related illnesses to
the municipal health commissioner. 13 The law also mandates noti-
fication of contacts by the infected individual or physician.' 4 This
Note explores the consequences and benefits of partner notifica-
tion for HIV, focusing on its likely impact on New York State. Part
I details the meaning and history of partner notification in the
United States. Part II presents arguments for and against partner
notification. Part III analyzes the New York law and argues that a
unique identifier system in lieu of name reporting would assuage
fears of privacy, encouraging a more effective implementation of a
partner notification system. This Note concludes that HIV is a
public health problem that cannot be ignored and must be com-
bated aggressively, in a manner that simultaneously promotes test-
ing and stunts transmission.
I. Name Reporting and Partner Notification in
the United States and New York
Every state' 5 has implemented a policy of name reporting for
AIDS.16 The information collected by state health departments in-
cludes "demographics, diagnostic facility, patient risk history, labo-
ratory analysis, clinical status, and treatment/service referrals."' 7
At the national level, patient and provider identifiers are deleted
from the data so that reporting is done without the disclosure of
infected individuals' names.' 8 The national system of AIDS re-
porting had developed almost from the inception of the epidemic, 19
12. See N.Y. PUB. HEALTH LAW § 2130 (McKinney 1999).
13. See id. § 2130(1).
14. See id. § 2133(1).
15. See CDC, AIDS Surveillance, supra note 1 (describing that data is collected
from all fifty states, the District of Columbia, U.S. dependencies and possessions and
independent nations in free association with the United States (Puerto Rico, the U.S.
Virgin Islands, Guam, American Samoa, the Republic of Palau, the Republic of the
Marshall Islands, the Commonwealth of the Northern Mariana Islands and the Feder-
ated States of Micronesia).
16. See id. ("[B]y 1985 all states had regulations requiring physicians and other
health care providers to report AIDS cases directly to the local or health depart-
ment," which in turn, share their data with the CDC.); see also Lawrence 0. Gostin &
James G. Hodge, The "Names Debate": The Case for National HIV Reporting in the
United States, 61 ALB. L. REV. 679, 705 (1998) [hereinafter Gostin & Hodge, The
"Names Debate"].
17. Gostin & Hodge, The "Names Debate", supra note 16, at 705-06.
18. See id. at 706.
19. See id. at 696.
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and caused little uproar. 20 Early on in the epidemic, those identi-
fied as AIDS' carriers often were on the brink of death already,
thus privacy issues were of little concern. 21 However, this claim is
not true today for HIV-positive individuals, especially those who
are asymptomatic and may remain so for years.22 Accordingly, it is
no surprise that the trend towards expanding the name reporting
system to HIV infected individuals has resulted in conflicted emo-
tions, despite the benefits of gathering epidemiological data about
the epidemic. 23
The current push for partner notification, especially in New
York, can most likely be attributed to advances in effective drug
therapy and recent reports of individuals putting others at risk of
contracting the virus.2 4 In New York, a name reporting and part-
ner notification bill, introduced by Senator Velella and Assembly
Member Nettie Mayersohn, was enacted on July 7, 1998.25
A. Meaning and History of Partner Notification
in the United States
Partner notification can be viewed as a combination of three
concepts that sometimes overlap: "(1) contact tracing; (2) the duty
of the infected persons to disclose their infection to a sexual part-
ner; and (3) the duty of health care providers to warn of sexual and
other risks to the partners of their infected patients. 2 a6
1. Contact Tracing
The practice of contact tracing generally enlists the help of pub-
lic health authorities who interview infected individuals (referred
to as "index" patients) to assemble a list of their contacts that may
have been exposed to HIV.a7 With this information, the authorities
20. See American Civil Liberties Union, HIV Surveillance and Name Reporting: A
Public Health Case for Protecting Civil Liberties (Oct. 1997) <http://www. aclu.org/
issues/aids/namereport.html> [hereinafter ACLU, HIV Surveillance].
21. See id.
22. See CDC, AIDS Surveillance, supra note 1 (stating that HIV is the causative
agent for AIDS).
23. See infra note 100 and accompanying text.
24. See Bill Laden, Albany Begins Drive to Lift HIV Confidentiality, N.Y. L.J.,
Dec. 1, 1997, at 1 ("[T]he recent case of Nushawn Williams, whom authorities suspect
may have infected numerous young women with HIV, has raised questions about the
privacy law and the legal rights of AIDS victims, and has propelled legislators to sug-
gest amendments to the law.").
25. See N.Y. PuB. HEALTH LAW §§ 2130, 2133 (McKinney 1999).
26. Gostin & Hodge, Piercing the Veil, supra note 6, at 14.
27. See id.
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attempt to trace the contacts and notify them of their potential in-
fection.28 The name of the index patient is not disclosed but may
be deduced under certain circumstances, 29 such as where the noti-
fied individual has only had one contact. This process then contin-
ues with any identified contact who likewise tests positive for
HIV.3°
The first contact tracing program dates back to the syphilis epi-
demic of the early sixteenth century.31 Once syphilis was recog-
nized as a sexually transmitted disease, individuals infected with
the disease were banished from communities, quarantined in spe-
cial hospitals and/or banned from public places.32 Prostitutes, who
were viewed as the carriers of sexual contagion, such as syphilis,
were subjected to government-sponsored medical inspection
known as reglementation throughout Europe and the United
States.33 The Illinois Board of Health even had the authority to
hospitalize women on mere suspicion of infection and to place
signs on their doors warning "suspected VD. 34
Thomas Parran, the newly-appointed Surgeon General during
Franklin Delano Roosevelt's presidency, decreed his goal to be the
eradication of the syphilis epidemic.35 With the assistance of fed-
eral funding, Parran began a national contact tracing program,
which included contact notification.36 This effort "marked the first
time in the United States that formal case finding and contact trac-
ing were applied to a sexually transmitted disease on a national
scale."' 37 However, the advent of penicillin in 1943 and its promise
to cure syphilis stymied the role that contact tracing would play in
reducing infection rates.38 Penicillin diminished the urgency for
notification, leaving the success of contact tracing undetermined.39
Although contact tracing is mainly the responsibility of state
health departments, the Centers for Disease Control and Preven-
28. See id.
29. See id.
30. See id.
31. See id. at 16.
32. See id. 16-17.
33. See id. at 17-19.
34. See id. at 19 (quoting Marvin S. Amstey, The Political History of Syphilis and
Its Application to the AIDS Epidemic, 4 WOMEN'S HEALTH ISSUES 16, 17 (1994)).
35. See id. at 21.
36. See id. at 21-22.
37. Id. at 22.
38. See id. at 22-23.
39. See David P.T. Price, Between Scylla and Charybdis: Charting a Course to
Reconcile the Duty of Confidentiality and the Duty to Warn in the AIDS Context, 94
DICK. L. REv. 435, 466 (1990).
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tion ("CDC"), as part of the federal Department of Health and
Human Services, provide funding to these state offices.4 ° The
CDC, in turn, requires state health departments to implement part-
ner notification programs according to certain guidelines.41 The
guidelines include models denominated "patient referral," "pro-
vider referral" or the hybrid "conditional referral. 42
The patient referral model enlists the aid of the index patient,
who is asked to disclose her seropositive status to her sexual con-
tacts and/or to injection drug users ("IDUs") with whom she has
shared syringes.43 The index patient is assisted by the public health
authorities to the extent that she is provided with medical informa-
tion, which she may pass on to her contacts.44 These programs do
not guarantee notification of contacts and do not provide for confi-
dentiality of the index patient, as she personally notifies her con-
tacts of the exposure to HIV.45
Provider referral programs, on the other hand, place the respon-
sibility of contact tracing in the hands of public health officials once
an index patient has disclosed a list of her contacts.46 Counseling is
provided to the contact, preferably face to face, by the official. 47
The anonymity of the patient is maintained because her name is
not revealed to contacts.48 Obviously, however, the contact may
deduce the name in certain circumstances. 49 Although provider re-
ferral programs generally are more costly because of the height-
ened involvement of health authorities, they tend to ensure the
transmission of high quality information. 50 They also typically re-
sult in a higher rate of notification. In a study conducted in North
Carolina, which assigned participants to either a patient referral
group or a provider referral group, seventy-eight of 157 partners
were successfully notified in the latter group whereas only ten out
of 153 were notified by the patient referral model group."
40. See Gostin & Hodge, Piercing the Veil, supra note 6, at 25-26.
41. See id. at 26.
42. Id.
43. See James T. Dimas & Jordan H. Richland, Partner Notification and HIV In-
fection: Misconceptions and Recommendations, 4 AIDS & PUB. POL'Y J. 206, 206.
44. See id.
45. See id.
46. See id.
47. See Gostin & Hodge, Piercing the Veil, supra note 6, at 27.
48. See Dimas & Richland, supra note 43, at 206.
49. See Gostin & Hodge, Piercing the Veil, supra note 6, at 27.
50. See Dimas & Richland, supra note 43, at 206.
51. See Suzanne E. Landis, M.D. et at., Results of a Randomized Trial of Partner
Notification in Cases of HIV Infection in North Carolina, 326 NEW ENG. J. MED. 101,
101 (1992).
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The third model, conditional referral, is a hybrid of the patient
and provider referral models.52 In this model, the index patient is
granted a limited period of time in which she may notify her con-
tacts before the health authority intervenes.53 As with the provider
referral model, the official does not disclose the identity of the in-
dex patient.54
2. Duty to Disclose
Partner notification sometimes denotes the "duty to disclose,"
whereby a duty exists to disclose one's sexually transmitted disease
to his/her sexual partner.55 Since the turn of the century, persons
aware of their infections have been responsible for disclosing con-
tagious conditions, such as whooping cough and tuberculosis, to
others with whom they were in contact.56 Today, in the context of
HIV/AIDS, the duty to disclose has been significantly extended.
In fact, the failure to disclose one's positive serostatus can result in
criminal -prosecution for putting others at risk for infection.57
Nushawn Williams, the man accused of having unprotected sex
with a teenage girl months after learning he was HIV-positive, was
charged with reckless endangerment in New York City. 8 By the
end of 1991, more than three hundred people had been prosecuted
for exposing others to HIV, and approximately fifty of those cases
resulted in conviction.59
3. Duty to Warn
The third component of partner notification, a physician's duty
to warn foreseeable third parties who may be endangered by the
patient, is based on the principle articulated in Tarasoff v. Regents
52. See Gostin & Hodge, Piercing the Veil, supra note 6, at 27.
53. See id.
54. See id.
55. See id. at 14-15.
56. See id. at 36-37.
57. See, e.g., IND. CODE ANN. § 16-41-7-1(d) (West 1998):
Carriers who know of their status as a carrier of a dangerous communicable dis-
ease described in subsection (a) [includes AIDS and HIV] have a duty to warn or
cause to be warned by a third party a person at risk of the following:
(1) The carrier's disease status.
(2) The need to seek health care such as counseling and testing.
58. See Lynda Richardson, Man Faces Felony Charge of Exposing Girl to H.I.V.,
N.Y. TIMES, Aug. 20, 1998, at B4 (noting that Williams also was suspected of infecting
more than a dozen women and girls in upstate New York).
59. See LAWRENCE BURRIS & HARLAN L. DALTON, Criminal Law, in AIDS LAW
TODAY 242 (Harlan L. Dalton et al. eds., 1993).
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of the Univ. of California.60 The California Supreme Court deter-
mined that physician-patient confidentiality must yield to the inter-
ests of third parties in similar situations where a special
relationship exists between the patient and the individual responsi-
ble for warning.61 As of 1996, twenty-three states had adopted a
Tarasoff-type duty by way of either judicial decision, legislative en-
actment or both.62
This duty to warn was extended to HIV/AIDS cases in Reisner v.
Regents of the Univ. of California.63 In this case, the California
Court of Appeals determined that a physician, who failed to inform
his patient that she had received a tainted blood transfusion and
thus was infected with HIV, was liable to the patient's sexual part-
ner who later contracted the virus from the patient. 64  Like
Tarasoff, a special relationship existed between physician and pa-
tient in Reisner, and the physician's responsibility did not stop at
just treating his patient, but extended to informing her of her
contagion.
Physician liability also has been found where a third party, with
whom the physician has established no physician-patient relation-
ship, was injured by the physician's patient. In DiMarco v. Lynch
Homes - Chester County, Inc. ,65 the Supreme Court of Penn-
sylvania found two physicians liable to a third party who had been
harmed as a direct result of the doctors' erroneous medical advice
to their patient.66 The court determined that a physician's duty re-
quired informing her patients of their disease or condition, not in-
60. 551 P.2d 334 (Ca. 1976). In Tarasoff, a California court imposed such a duty
on psychotherapists whose patient expressed an intent to kill his victim. Because the
patient was mentally unstable and had expressed a desire to kill a readily identifiable
individual, the physicians should have alerted the victim that she was in danger. See
id.
61. See id. at 343 (finding that a "special relationship" exists between a patient and
his/her doctor or psychotherapist such that affirmative duties for the benefit of third
persons may arise).
62. See Christine E. Stenger, Taking Tarsoff Where No One Has Gone Before:
Looking at "Duty to Warn" Under the AIDS Crisis, 15 ST. Louis U. PuB. L. REV. 471,
476 (1996).
63. 31 Cal. App. 4th 1195 (1995).
64. See id.
65. 583 A.2d 422 (Pa. 1990). The physicians had given erroneous medical advice
to their patient concerning the contagious nature of her illness, which resulted in in-
jury to the third-party plaintiff. The physicians only were required to give correct
medical advice to their patient concerning the transmission of the hepatitis virus that
she may have contracted; they were not required to inform third persons, foreseeable
or not. See id.
66. See id.
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forming every possible third-party plaintiff.67 This scenario would
suggest that the physicians' duty is to inform, rather than to warn.
As long as the physician correctly informs her HIV-diagnosed pa-
tient concerning the modes of transmission, she should be free
from professional liability. Reisner emphasizes this duty to inform
by finding the physician liable to an injured third party for failure
to warn his patient, not for failure to warn the third party directly. 68
The reasoning in Reisner would not seem to require partner notifi-
cation; rather, it serves as a reminder to physicians about their pre-
existing duty to fully inform patients about their disease. 69
Although courts have laid down a tradition that requires physi-
cians to warn family members and others in close proximity to the
patient of the contagious nature of the patient's disease,70 these
cases are "generally characterized by the inability of the patient
either to adapt his conduct so as to avoid or minimize the risk of
infection or to communicate adequately to third parties the nature
of the risk."' 71 Moreover, these duty-to-warn cases generally in-
volved minor children or seriously debilitated people. 72 It thus fol-
lows that opponents of partner notification likely would respond
that this tradition does not apply to HIV because the index patient
is informed of her condition and the ways to control transmission
to others when she is diagnosed. 73
Furthermore, the foundation upon which the duty to warn has
been erected is factually distinguishable from that in the HIV situa-
tion. In Tarasoff, the physician was a psychotherapist and the pa-
tient a mentally deranged individual who had made explicit
comments about his intent to murder a readily identifiable wo-
man.74 However, in reality, the physician who diagnoses an index
67. See id.
68. See Reisner, 31 Cal. App. 4th at 1195 (finding physician liability in an action by
a man who had contracted HIV through his girlfriend due to physician's failure to
inform his patient that she had received tainted blood in a transfusion and was HIV
positive).
69. See Stenger, supra note 62, at 502.
70. See Price, supra note 39, at 449 (citing Davis v. Rodman, 227 S.W. 612 (Ark.
1921); Jones v. Stanko, 160 N.E. 456 (Ohio 1928); Wojcik v. Aluminum, 183 N.Y.S.2d
351 (1959); Simonsen v. Swenson, 177 N.W. 831 (Neb. 1920)).
71. Id. at 450.
72. See id. at 449 (citing Davis, 227 S.W. at 612; Jones, 160 N.E. at 456; Wojcik, 183
N.Y.S.2d at 351 (1959); Simonsen, 177 N.W. at 831).
73. See, e.g., N.Y. PUB. HEALTH LAw § 2781(3) (McKinney 1999) (requiring
health officials testing patients to inform them of the nature of the disease, the possi-
bility of discrimination, and ways to curb transmission).
74. See Tarasoff v. Regents of the Univ. of California, 551 P.2d 334, 339 (Ca.
1976).
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patient with HIV is generally not a psychotherapist, nor is the in-
dex patient generally insane. More likely, the physician is a medi-
cal doctor who can explain the known routes of HIV transmission
and the ways to prevent it. The patient, through behavior modifi-
cation, can stop the chain of transmission, as can his/her contact via
protective measures. An individual who desires to kill another,
whether it be with a physical weapon or with a virus, differs greatly
from one who is infected with a virus and will take the necessary
precautions to prevent its transmission. Additionally, the duty to
warn applies to future harm that may occur to an individual from
the intended acts of another.75 Partner notification, however, at-
tempts to retrospectively warn those potentially infected by the vi-
rus, which in its own way may make a stronger case for partner
notification - the harm, e.g., exposure, has already occurred and is
no longer speculative.
Although many of the duty-to-warn cases do involve contagious
diseases such as hepatitis, HIV/AIDS can be distinguished from
those infectious diseases. Not surprisingly, the stigma associated
with HIV/AIDS is far greater than that associated with any other
infectious disease.76 "The privacy interest in one's exposure to the
AIDS virus is even greater than one's privacy interest in ordinary
medical records .... The potential for harm in the event of a non-
consensual disclosure is substantial. ' 77 Additionally, HIV/AIDS is
different in kind from diseases such as tuberculosis because of the
determinate role that behavior modification plays in transmission
of the former. Adhering to certain precautions can prevent the
spread of HIV, whereas tuberculosis is air-borne. 78 While incur-
able, 79 Hepatitis B also is different from HIV because vaccines ex-
75. See id. at 340.
76. See NYC Bar, Partner Notification, supra note 7, at 8; see also Herek &
Capitanio, infra note 77 and accompanying text.
77. Doe v. Borough of Barrington, 729 F. Supp. 376, 384 (D.N.J. 1990) (recogniz-
ing a constitutional privacy right in one's HIV status). See generally Gregory M.
Herek, Ph.D. & John P. Capitanio, Ph.D., A Second Decade of Stigma: Public Reac-
tions to AIDS in the United States, 1990-91 (1997) <http://psychology.ucdavis.edu/rain-
bow/html/aids stigma-paper.html> (outlining the discrimination still faced by
individuals infected with HIV/AIDS today including employment discrimination and
equal treatment by health professionals arising from fear and stigma surrounding the
disease).
78. See Gostin & Hodge, Piercing the Veil, supra note 6, at 686.
79. See Marc Kaufman, Hepatitis B Vaccine Effort Draws Fire; Critics Cite Reports
of Adverse Effects in Opposing Mandatory Inoculations of Children, WASH. POST,
Feb. 2, 1999, at Z1l. The hepatitis B virus infects about 200,000 Americans annually.
At least 36 states, however, require the vaccine, which consists of a series of three
shots, before a child can register for school. See id.
1466
HIV NAME REPORTING
ist for Hepatitis B, capable of preventing. its spread for at least
fifteen years.8" However, both diseases are spread through blood
and other bodily fluids, and are found most frequently among
IDUs and people engaging in high-risk sexual activities in the
United States.81 Still, Hepatitis B, while more readily transmissi-
ble, is less likely to be fatal.82
B. Name Reporting and Partner Notification in New York
The new law enacted by New York in the summer of 1998 man-
dates that physicians and others authorized to order diagnostic
tests, as well as laboratories performing these tests, must report
any person testing positive for HIV, AIDS or HIV-related illness
to the municipal health commissioner.83 This commissioner must
then forward the information, which contains the identifying infor-
mation of the index patient and any contacts, to the municipal
health commissioner of the municipality where the disease oc-
curred.8s Although name reporting of HIV would serve certain ep-
idemiological benefits such as "facilitat[ing] the study of the course
of the disease and allow[ing] better targeting of resources and pre-
vention efforts, 85 many assert that it is a great deterrent to
testing."6
New York legislation continues to state that, in the case of con-
tacts residing outside of the municipality, the commissioner will
send the report to the particular contact's municipality, whose
commissioner will make a good faith effort to notify the contact.87
The commissioner will accompany notification with information re-
lating to HIV treatment and prevention,88 ensuring, at the very
least, that accurate information is disclosed.89 During the notifica-
tion process, the commissioner or authorized official is not permit-
ted to divulge the identity of the index patient or the identity of
any other contact.90
80. See Ron Geraci, Do You Have Hepatitis C?, MEN'S HEALTH, Mar. 5, 1999.
81. See Kaufman, supra note 79, at Z1l.
82. See Stenger, supra note 62, at 488; see also Ron Geraci, supra note 80 (stating
that most cases of Hepatitis B resolve themselves but almost 15% become chronic
and can cause cirrhosis or liver cancer).
83. See N.Y. PUB. HEALTH LAW § 2130(1) (McKinney 1999).
84. See id. §§ 2130(2)-(3).
85. NYC Bar, Name Reporting, supra note 5, at 1.
86. See supra notes 168-169 and accompanying text.
87. See N.Y. PUB. HEALTH LAw § 2131 (McKinney 1999).
88. See id. § 2133(2).
89. See Dimas & Richland, supra note 43, at 206.
90. See N.Y. PUB. HEALTH LAw § 2133(3) (McKinney 1999).
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The law also stipulates that no criminal or civil liability will result
for any index patient's failure to cooperate in contact tracing, and
adds a safety provision for index patients threatened by domestic
violence.91 Other safety precautions are the ones given to health
officials who must report or notify partners: "Good faith reporting
or disclosure pursuant to this title shall not constitute libel or slan-
der or a violation of the right of privacy or privileged communica-
tion. '92 Furthermore, immunity from civil and criminal liability is
granted for good faith attempts at reporting.93 The physician also
is given the alternative of notifying contacts if she has notified the
patient of her intent and given the patient an opportunity to ex-
press a preference as to notification.94
Finally, the option of anonymous testing still is retained by the
new law. Section 2138 emphasizes that: "Nothing in this article
shall be interpreted to eliminate the anonymous testing option pro-
vided for in section twenty seven hundred eighty-one of this chap-
ter."'95 Unlike other infectious diseases, anonymous testing has
been available for HIV at publicly-funded sites in the United
States since 1985.96 In confidential testing, a person's name is
linked to the specimen, and the result of the test is recorded in the
medical chart with a name.97 Anonymous testing, on the other
hand, uses a unique identifier, rather than the patient's name, to
link the specimen with the test result, and the results are not re-
corded in the medical chart.98
II. The Debate Over Name Reporting and Partner Notification:
The Ramifications of Disclosure
It is no secret that name reporting and partner notification are
controversial and emotionally-charged issues. At the heart of the
debate, the welfare of unknowingly HIV-infected individuals is di-
rectly pitted against the privacy interest one has in her own seros-
tatus. It is difficult, if not impossible, to draw clear lines between
91. See id. §§ 2136(3), 2137.
92. Id. § 2136(1).
93. See id. § 2136(2).
94. See id. § 2782(4)(a)(4).
95. Id. § 2138.
96. See A. B. Bindman et al., Multistate Evaluation of Anonymous HIV Testing
and Access to Medical Care, 280 JAMA 1416 (1998) (stating that as of October 1998,
forty states have publicly funded anonymous testing sites for HIV, and all fifty states
have publicly funded confidential testing sites).
97. See id.
98. See id.
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right and wrong. The following are arguments posited by propo-
nents and opponents of name reporting and partner notification.
A. The Benefits of Name Reporting and Partner Notification
Proponents of name reporting and partner notification ground
their argument in the changing face of the disease: once found pri-
marily in male homosexuals and IDUs, HIV has evolved. "[T]he
epidemic American society now faces is no longer a plague of un-
stoppable, deadly disease among predominantly gay persons, but a
potentially controllable chronic condition with increasing effects on
heterosexuals, women, and children."99 As HIV has affected more
of the American population, the push to decrease the spread of
HIV infection has increased considerably. The need for epidemio-
logical data to understand and control HIV is crucial, especially
considering the benefits that recent advances have already shown:
"From a public health and epidemiological perspective, the advan-
tages of tracking and profiling HIV are significant, as HIV marks
the beginning of the disease process rather than the end. In con-
trast, AIDS surveillance is triggered by events marking the late-
stage progression of disease."' °
1. Advances in Drug Therapy
The practices of name reporting and partner notification are fur-
ther justified by the recent success of drug therapies. Encouraging
trends in AIDS cases in the United States have been attributed
primarily to the effect of antiretroviral therapies on HIV-positive
individuals.10 1 AIDS deaths declined twenty-three percent in 1996
compared to 1995, indicating that the therapies are having a signifi-
cant impact on the rate of HIV progression.102 In addition, recent
studies varying antiretroviral regimens have shown significant im-
provements in mortality and AIDS-free survival for men and wo-
99. Gostin & Hodge, The "Names Debate," supra note 16, at 710.
100. Texas Department of Health Bureau of HIV and STD Prevention, Unique
Identifier Reporting for HIV Infection Surveillance (Nov. 1997) <http://
www.tdh.state.tx.us/hivstd/stats.htm>.
101. See U.S. Department of Health and Human Services, Update: Trends in AIDS
Incidence - United States, 1996, 46 MORBIDITY & MORTALITY WKLY. REP. 861 (1997)
[hereinafter USHHS, Update]. Antiretroviral therapy achieving maximum HIV sup-
pression generally includes a mixture of two nucleosides and protease inhibitor. See
HIV/AIDS Information Center, Compliance with HIV Treatment Guidelines Linked
to Physician Experience (July 2, 1998) <http://www.ama-assn.org>.
102. See USHHS, Update, supra note 101 ("From 1995 to 1996, deaths declined in
all four geographic regions . . . ; among men and women; among all racial/ethnic
groups; and in all risk/exposure categories ... ").
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men. 10 3 Individuals free of AIDS who took the less effective
regimen were nearly three times more likely to progress to AIDS
or die than those in the other group.'0 4 Antiretroviral agents also
have been known to reduce viral loads in individuals for periods of
months to years,1 °5 reflecting the strides medicine has made since
the beginnings of the epidemic.
Furthermore, recent reports indicate that a triple therapy regi-
men without protease inhibitors can effectively suppress HIV. 10 6 A
study was conducted in 173 drug-naYve HIV-positive individuals in
which eighty-seven received triple-drug therapy while eighty-six re-
ceived two-drug therapy.10 7 The results showed that triple-drug
therapy resulted in undetectable levels of the virus in eighty-six
percent of patients after sixteen weeks, while two-drug therapy
only resulted in undetectable levels of the virus in forty-three per-
cent of patients after the same week period.108 Thus, it has been
asserted that "'HIV has become a potentially manageable disease
on a multiple decade timetable."' 10 9 Advancements in medical re-
search have even created optimism about the development of a
vaccine.110
Treatment with zidovudine also has reduced the rate of perinatal
transmission of HIV. 11 Perinatal transmission accounts for virtu-
103. See Robert S. Hogg et al., Improved Survival among HPV-infected Individuals
Following Initiation of Antiretroviral Therapy, 279 JAMA 450 (1998) (attributing im-
provement of HIV-infected individuals to new antiretroviral therapy strategies that
included separating patients into two therapy regimens: ERA-I included zidovudine-,
didanosine-, or zalcitabine-based therapy and ERA-II included lamivudine or
stavudine).
104. See id. (noting that the ERA-II group showed marked improvements).
105. See Roy M. Gulick, HIV Treatment Strategies: Planning for the Long Term,
279 JAMA 957 (1998).
106. See HIV/AIDS Information Center, Triple Therapy Without Protease Inhibitor
Effectively Suppresses HIV (June 29, 1998) <http://www.ama-assn.org>. The triple
drug therapy consisted of a combination of the drugs abacavir, lamivudine and
zidovudine. See id.
107. See id. (stating the two-drug therapy group received lamivudine and
zidovudine only).
108. See id.
109. HIV/AIDS Information Center, Long-term Antiretroviral Compliance: Pa-
tients Can't Do It Alone (July 2, 1998) <http://www.ama-assn.org> (quoting Dr. Ste-
fano Vella of Italy).
110. See HIV/AIDS Information Center, Geneva Data Offer "Sobering" View of
HIV Treatment (June 30, 1998) <http://www.ama-assn.org>.
111. See Public Health Service Task Force Recommendations for the Use of Antire-
troviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for
Reducing Perinatal HPV-i Transmission in the United States (Jan. 30, 1998) <http://
hivinsite.ucsf.edu/medical/tx-guidelines/ 2098.37e2.htm>.
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ally all new HIV infections in children.' 12 "As of September 30,
1997, perinatal transmission of HIV accounted for 7310 (one per-
cent) of the 626,334 total AIDS cases in adults and children re-
ported to the CDC by state and territorial health departments." 113
New York State alone comprised twenty-seven percent of the per-
inatally transmitted infections." 4 A 1996 study showed that the
HIV transmission rate for infants receiving a placebo was 22.6%,
as compared with a 7.6% rate for infants receiving zidovudine."15
These differences amounted to a sixty-six percent reduction in the
risk of transmission."16 The Institute of Medicine has recom-
mended that HIV testing be universal and added to the standard
battery of prenatal tests. 11 7 Partner notification may apprise preg-
nant women of their exposure to HIV and potentially prevent their
children from contracting the disease.
Partner notification may help HIV-positive individuals make
better use of available drugs by informing them that they have
been exposed to the disease in hopes of getting them into treat-
ment before any symptoms of infection occur. "Early detection of
the virus is considered increasingly important since a new class of
AIDS drugs called protease inhibitors has proven effective in treat-
ing the disease in many people."1 ' 8 Research has indicated that
these new drug therapies are more effective if begun soon after
infection."19 Name reporting may help to develop even more effec-
tive treatments or improve those already available.
2. Cost Efficiency of Partner Notification
Proponents of partner notification also argue that money spent
on implementing such programs is money well spent. Colorado
112. See Centers for Disease Control and Prevention, Update: Perinatally Acquired
HIVIAIDS - United States, 1997, 46 MORBIDITY & MORTALITY WKLY. REP. 1086
(1997).
113. Id.
114. See id.
115. See id.
116. See id.
117. See Centers for Disease Control and Prevention, Status of Perinatal HIV Pre-
vention in the United States: CDC Statement Following the Release of the Institute of
Medicine Report (Oct. 14, 1998) <http://www.cdc.gov> (stating that the CDC has rec-
ommended since 1994 that all pregnant women be offered HIV testing as part of
prenatal care, and if infected, be offered an AZT regimen).
118. Richard Pdrez-Pefia, Bill in Albany to Track H.I.V. Gains Backing, N.Y.
TIMEs, June 19, 1998, at Al.
119. See American Civil Liberties Union, HIV Partner Notification: Why Coercion
Won't Work, ACLU REPORT 1, 2 (March 1998) [hereinafter ACLU, Why Coercion
Won't Work].
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health officials calculated that every dollar spent on HIV partner
notification saves $7.20 in clinical care costs for AIDS patients.12 0
This figure assumes that each partner who elects to be tested as a
result of notification will transmit HIV to one less partner and fifty
percent of those tested would develop AIDS. 1
Another way to understand the cost-efficiency of partner notifi-
cation is to analyze the increasing costs associated with HIV/AIDS
drug therapy and the subsequent economic benefits derived from
halting transmission to others. Several years ago, basic HIV ther-
apy amounted to an annual cost of $3000, whereas basic therapy in
1998, which currently involves four or five drugs, has risen to more
than $12,000 annually. 22
3. No Effective Alternatives
Many proponents of name reporting rally against non-name re-
porting systems, such as the unique identifier system used in sev-
eral states, which they view as ineffective in collecting data to study
the disease. Maryland's unique identifier system, in effect since
June 1, 1994, is a twelve digit number consisting of the last four
digits of an individual's Social Security number, date of birth, race/
ethnicity and gender.1 23 An evaluation of Maryland's system from
July 1994 through December 1996 found that twenty-nine percent
of 9971 laboratory reports entered into the system were missing a
portion of the unique identifier, usually the social security
number. 24 The Maryland system was also plagued by a fifty per-
cent rate of completeness, a large number of duplicate reports and
lack of HIV risk information.125
Texas also instituted a unique identifier system in March 1994,
but recently abandoned it in favor of HIV reporting by name,
120. See Dimas & Richland, supra note 43, at 207.
121. See id.
122. See David N. Rose, AIDS Drug Regimens that are Worth Their Costs, 279
JAMA 160 (1998).
123. See American Civil Liberties Union, The Maryland Lesson: Conducting Effec-
tive HIV Surveillance with Unique Identifiers, ACLU REPORT (Dec. 1997) <http:II
www.aclu.org/issues/aids/mdnamereport.html> [hereinafter ACLU, The Maryland
Lesson]. Texas's unique identifier system also used these same components. See
Texas Department of Health, HIV Reporting by Name: Why Texas is Changing (vis-
ited Mar. 11, 1999) <http://www.tdh.state.tx.us/hivstd>.
124. See Centers for Disease Control and Prevention, Evaluation of HIV Case Sur-
veillance Through the Use of Non-Name Unique Identifiers - Maryland and Texas,
1994-1996, 46 MORBIDITY & MORTALITY WKLY. REP. 1254 (1998) [hereinafter CDC,
Evaluation of HIV Case Surveillance] .
125. See id.
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which will be effective January 1, 1999.126 However, this change
will not affect the availability of anonymous HIV testing. 12 7 Texas'
decision to stop using the unique identifier system stems from in-
complete codes collected throughout the years: from a pool of
20,000 reports in the last three years, only forty-nine percent have
been complete. 128
4. Name Reporting is not a Deterrent to Testing
Studies have shown that name reporting and partner notification
are not significant deterrents to testing.12 9 One study conducted
last year revealed that there were no significant declines in the to-
tal number of HIV tests provided at counseling and testing sites in
the months immediately after implementation of HIV reporting
occurred in any of the six states studied, other than those expected
from previous trends. 13  In fact, the study found increases in Ne-
braska (15.8%), Nevada (48.8%), New Jersey (21.3%) and Tennes-
see (62.8%).131 Predicted decreases occurred in Louisiana and
Michigan (10.5% and 2.0%, respectively). 32 All six states showed
increases in testing of at-risk heterosexuals. 33 Only two states
showed minimal declines for men who have sex with men.13 4 Three
states had declines for IDUs.'35
126. See Texas Department of Health, HIV Reporting by Name Adopted in Texas
(visited Dec. 13, 1998) <http://www.tdh.state.tx.us/hivstd/input.htm> ]hereinafter
TDH, HIV Reporting by Name].
127. See id.
128. See Texas to Switch from Codes to Names to Track HIV Cases, AIDS POL'Y &
LAw, Feb. 20, 1998, at 1, 11.
129. See A. K. Nakashima et al., Effect of H1V Reporting by Name on Use of HIV
Testing in Publicly Funded Counseling and Testing Programs, 280 JAMA 234 (1998)
(explaining studies that found name reporting and partner notification to be deter-
rents were flawed either because they targeted people seeking anonymous testing,
who were naturally more likely to be concerned about confidentiality than the aver-
age person, or conducted their studies before highly effective antiretroviral therapies
were available, or both).
130. See id.
131. See id.
132. See id.
133. See id. (chronicling increases for heterosexuals were as follows: Louisiana,
10.5%; Michigan, 225.1%; Nebraska, 5.7%; Nevada, 303.3%; New Jersey, 462.9%;
Tennessee, 603.8%).
134. See id. ("Declines in testing occurred among men who have sex with men in
Louisiana (4.3%) and Tennessee (4.1%) after HIV reporting; testing increased for
this group in Michigan (5.3%), Nebraska (19.6%), Nevada (12.5%), and New Jersey
(22.4%).").
135. See id. ("Among injection drug users, testing declined in Louisiana (15%),
Michigan (34.3%), and New Jersey (0.6%) and increased in Nebraska (1.7%), Nevada
(18.9%), and Tennessee (16.6%).").
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The Texas Department of Health ("TDH") conducted a study in
1996 and 1997 in which HIV prevention workers interviewed 615
Texans in three risk categories for HIV (men who have sex with
men, IDUs and high risk heterosexuals). 136 Eighty-five percent of
those interviewed said that they were likely to test for HIV in the
next year.'37 Seventeen percent expressed some concern about
named reporting of HIV test results, but only two percent cited
concerns over confidentiality or reporting as the most important
reason for delaying or avoiding testing. 38
Moreover, from a survey of 399 patients who had not been
tested for HIV, only eighteen cited discrimination and confidential-
ity concerns as factors in their decision, showing that despite wide-
spread misconceptions about partner notification, the deterrence
to testing is small.' 39 This survey also showed that ninety-one per-
cent of respondents believed that HIV-positive index patients
should apprise their sexual partners of their possible exposure to
HIV.
140
5. Allocating and Improving Scarce Resources
After abandoning its unique identifier system, TDH argued that
HIV reporting by name was necessary to "make sure that re-
sources get to the communities that need them most.' 141 TDH
uses AIDS case numbers to allocate HIV treatment resources, but
these numbers do not accurately reflect the people infected with
HIV. 41 Thus, communities with large numbers of asymptomatic
HIV individuals do not get the resources they need. 143 Addition-
ally, TDH has argued that it cannot get a reliable estimate on the
number of HIV infected individuals in Texas without HIV report-
ing.144 Without this number, improving HIV prevention and serv-
ices programs is difficult, especially considering the increasing time
lag between HIV infections and AIDS. 145 The subtle trends in in-
136. See Texas Department of Health, HIV Reporting by Name: The Impact on
HIV Testing (visited Mar. 11, 1999) <http://www.tdh.state.tx.us/hivstd>.
137. See id.
138. See id.
139. See Dimas & Richland, supra note 43, at 206.
140. See id. at 208.
141. Texas Department of Health, HIV Reporting by Name: Questions & Answers
(visited Mar. 11, 1999) <http://www.tdh.state.tx.us/hivstd>.
142. See id.
143. See id.
144. See id.
145. See id.
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fection rates among different groups cannot be gauged without
data on HIV.146
B. Arguments Against Name Reporting and
Partner Notification
1. Threats to Confidentiality
Perhaps the most basic argument against name reporting and
partner notification is the potential breach of patient confidential-
ity and the degeneration of the doctor-patient relationship:
"Named reporting also by its nature requires a breach of the thera-
peutic relationship, because the physician, by law, must report con-
fidential information to the health department. ' 147  Partner
notification results in a similar breach, because although the physi-
cian does not disclose the name of the index patient, she still must
inform contacts of the index patient, not unreasonably resulting in
the index patient's fear of discovery.
In states requiring partner notification, the contours of what
would be the inner-sanctum of the doctor-patient relationship are
mandated by statute. Some states impose penalties on HIV posi-
tive individuals who fail to notify contacts,'148 and others authorize
physicians and public health officials to notify contacts, even with-
out the patient's consent. 149
The creation of databases containing the names of, infected indi-
viduals and their contacts increases the possibility of further
breaches in confidentiality. There already have been such
breaches, including the theft of a computer containing the names of
people with AIDS from a public health office in Sacramento, Cali-
fornia.150 State experts reviewing a backup computer tape found a
list of names and characteristics of about sixty AIDS patients that
146. See id.
147. See Gostin & Hodge, The "Names Debate," supra note 16, at 684.
148. See, e.g., IND. CODE ANN. § 35-50-3-3 (West 1994).
149. See, e.g., CONN. GEN. STAT. ANN. § 19a-584 (West 1997):
A public health officer may inform or warn partners of an individual that
they may have been exposed to the HIV virus under the following condi-
tions: (1) The public health officer reasonably believes there is a significant
risk of transmission to the partner; (2) the public health officer has coun-
seled the protected individual regarding the need to notify the partner and
the public health officer reasonably believes the protected individual will not
inform the partner; (3) the public health officer has informed the protected
individual of his intent to make such disclosure.
150. See Richard C. Paddock, Thieves Steal Computer Containing Confidential List
of 60 AIDS Victims, L.A. TIMES, July 9, 1987, at 3.
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dated back more than a year and should have been erased
earlier. 15'
There have also been leaks of information on computer discs
from the Pinellas County Health Unit in Florida, which may have
contained the names of approximately 4000 individuals infected
with HIV.115 The database contained telephone numbers, ad-
dresses, dates of birth and the manner by which individuals con-
tracted AIDS.a53 Investigation into this incident revealed the
practice of Florida's employees visiting hospitals and doctors carry-
ing laptops and discs containing the entire list of HIV-positive indi-
viduals for the county in which they worked.154 Opponents of HIV
partner notification fear that health officials privy to the HIV sero-
status of so many individuals will continue to compromise confi-
dentiality by leaking the information.
Disclosure of one's serostatus to others may also lead to domes-
tic violence. One study showed that forty-five percent of health
care providers serving HIV-positive women reported that they
have patients who feared domestic violence as a result of partner
notification. 15 5 One-quarter of these providers had patients who
actually had been assaulted by their partners upon notification.1 56
Additional breaches in confidentiality may come from the con-
tact who is notified by the physician or public health authority.
Although statutory requirements prohibit disclosure to non-privi-
157leged sources, the name of an index patient whose identity is
deducible by the contact may be leaked by that contact.1 58 In cer-
tain situations, it could be virtually impossible to determine where
a breach occurred, especially if it was perpetrated by an angered
151. See id.
152. See Sue Landry, AIDS List is Out, ST. PETERSBURG TIMES, Sept. 20, 1996, at
1A.
153. See id.
154. See Sue Landry & Tim Roche, Lawsuit Filed Over AIDS List, ST. PETERS-
BURG TIMES, Sept. 24, 1996, at 1A.
155. See ACLU, Why Coercion Won't Work, supra note 119, at 9 (citing Karen H.
Rothberg et al., Domestic Violence and Partner Notification: Implications for Treat-
ment and Counseling of Women with HIV, 50 JAMWA 3:87 (1995)).
156. See id. (citing Karen H. Rothberg et al., Domestic Violence and Partner Notifi-
cation: Implications for Treatment and Counseling of Women with HIV, 50 JAMWA
3:87 (1995)).
157. See, e.g., N.Y. PUB. HEALTH LAw § 2135 (McKinney 1999) ("All reports or
information secured by the department, municipal health commissioner or district
health officer.., shall be confidential except in so far as is necessary to carry out the
provisions of this title.").
158. See Price, supra note 39, at 469.
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contact. Not surprisingly, it would be difficult to enforce laws
prohibiting disclosure by contacts.
Opponents of name reporting and partner notification have ral-
lied behind programs such as anonymous testing and unique identi-
fier systems. Another system that would not breach confidentiality
but may pose other problems is the use of a unique identifier that is
not comprised of the last four digits of a patient's social security
number. 159 An example of this identifier is a word or phrase that
the patient chooses herself, similar to e-mail addresses used on the
internet.160 This identifier need not in any way be linked to the
patient, assuring perfect confidentiality. However, this system re-
lies completely on the patient's cooperation, making the collection
of a comprehensive pool of data in comparison with a name report-
ing system more difficult.
2. Stigma and the Inadequacy of Legal Protections
Mandatory name reporting and partner notification may be
more palatable to the general populace if the stigma surrounding
HIV/AIDS was not so strong. In a study conducted by Gregory M.
Herek, Ph.D. and John P. Capitanio, Ph.D. at the University of
California at Davis, it was demonstrated that the stigma of AIDS is
still alive and strong.16' The study examined attitudes towards peo-
ple with AIDS ("PWA") in the second decade of the disease.162 It
found that between one-third and one-fifth of the general public
holds negative feelings towards PWA, believes that they deserve
their illness, or even supports punitive measures to be taken
against them.' 63 The study further revealed that many misconcep-
tions around transmissibility of the disease still exist.' 64
Legal protections are necessary to stop discrimination against
PWA. Unfortunately, current protections are inadequate in ac-
complishing this goal. As illustrated by the Americans with Disa-
bilities Act ("ADA"), although a law may be able to prohibit
discrimination in theory, it cannot always control it in practice. For
159. See Symposium, Queer Law 1999: Current Issues in Lesbian, Gay, Bisexual,
Transgendered Law, 27 FORDHAM URB. L.J. (forthcoming Oct. 1999) (citing Cathe-
rine Hanssens, Esq., Lambda Legal Defense and Education Fund).
160. See id.
161. See Herek & Capitanio, supra note 77.
162. See id.
163. See id.
164. See id. Of the 538 surveyed, roughly half thought transmission of HIV was
likely when two uninfected homosexual men had intercourse without condoms, when
a person shared a drinking glass with an HIV-positive person, was coughed or
sneezed on by a infected individual, or was bitten by an insect. See id. at tbl. 2.
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example, in Bragdon v. Abbott165 the Supreme Court recently de-
termined that asymptomatic HIV infection is a disability for ADA
purposes, thereby prohibiting employment discrimination against
HIV-positive individuals. 166 Still, the Court cannot eliminate the
obvious social stigma attached to the disease. Even the ADA
working at full capacity cannot prevent a seropositive individual
from suffering discrimination in social situations and by loved
ones.
167
3. Name Reporting and Partner Notification Deter Testing
A common argument against name reporting and partner notifi-
cation programs is that they will deter people from voluntary HIV
testing. According to some, "while the goal of increased tracking
of HIV infection is to bring those with HIV into the public health
system and to obtain more accurate epidemiological data, name re-
porting will likely have the opposite effect. ' '168 Studies suggest that
a significant number of individuals tested anonymously for HIV
would not have undergone testing if their names would have been
reported to public health authorities. 69
Moreover, if the ultimate goal is to get people tested, treated
and engaged in less risky behavior as quickly as possible, then
name reporting and partner notification may have a deleterious ef-
fect.170 Research indicates that when anonymous testing is avail-
able, the average amount of time spent deciding to be tested can be
reduced by more than one half, from a mean of twelve months to a
mean of five months. 71 Moreover, more individuals return for
their results at anonymous testing centers than at centers that prac-
165. 524 U.S. 624 (1998).
166. See id.
167. See ACLU, HIV Surveillance, supra note 20.
168. See id.
169. See id. (citing Susan M. Kegeles et al., Many People Who Seek Anonymous
HIV-Antibody Testing Would Avoid it Under Other Circumstances, 4 AIDS 585, 586
(1990) (observing that over sixty percent of individuals tested anonymously would not
have tested if their names were reported to public health officials); see also Gostin &
Hodge, Piercing the Veil, supra note 6, at 33 (citing Centers for Disease Control &
Prevention, U.S. Dep't of Health & Human Servs., Partner Notification and Confiden-
tiality of the Index Patient: Its Role in Preventing HIV, 17 SEXUALLY TRANSMITTED
DISEASES 113, 113-14 (1990)).
170. See ACLU, HIV Surveillance, supra note 20 (citing Laura Fehrs et al., Trial of
Anonymous Versus Confidential Human Immunodeficiency Virus Testing, 2 LANCET
391 (1998)).
171. See id.
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tice name reporting. 172 The number of individuals failing to return
likely would increase where testing entailed not only name disclo-
sure to authorities, but also was followed by partner notification.
Additionally, fears of discrimination and stigmatization are so
strong that many travel across state lines to obtain anonymous test-
ing. 173 Performed in conjunction with name reporting, partner no-
tification appears to add barriers to an already emotionally-
charged situation. Partner notification is self-defeating if it acts as
a deterrent to testing. Fewer contacts will be notified if fewer peo-
ple are willing to be tested.
4. The Failure of Partner Notification to
Eradicate the Spread of Syphilis
Although sexually-transmitted, HIV/AIDS is different in degree
from other STDs. HIV/AIDS cannot be rendered non-infectious
like syphilis and gonorrhea, meaning that any partner notification
program for HIV/AIDS-infected individuals would have to con-
tinue throughout the person's existence, making it considerably
more expensive than those employed for other STDs. 74 Despite
the central role partner notification played in syphilis treatment
programs in the 1940s, it is unclear whether it had an effect on
reducing transmission.175 In fact, both syphilis and gonorrhea in-
fections have increased in the past twenty years, leading many to
question the effectiveness of partner notification measures.176
Even the CDC recognized this dilemma, attributing partner notifi-
cation's failure to control syphilis to the fact that syphilis affects a
large number of illegal drug users, rendering notification of con-
tacts difficult and sometimes impossible. 77 HIV infection also is
largely related to IDUs: The demographics of HIV are changing
from largely gay and bisexual men in the first decade of the epi-
demic to people of color and IDUs in the second decade. 178
172. See id. A study conducted in North Carolina showed that 30.3% of people
undergoing confidential testing did not return, as compared to only 8.2% of anony-
mously tested individuals. See id. (citing Irva Hertz Picciotto et al., HIV Test-Seeking
Before and After the Restriction of Anonymous Testing in North Carolina, 86 AM. J.
PUB. HEALTH 1446, 1448 (1996)).
173. See id.
174. See NYC Bar, Partner Notification, supra note 7, at 3, 8.
175. See id. at 3.
176. See id.
177. See ACLU, Why Coercion Won't Work, supra note 119, at 6. (citing Centers
for Disease Control, Alternative Case-Finding Methods- in a Crack-Related Syphilis
Epidemic - Philadelphia, 40 MORBIDITY & MORTALITY WKLY. REP. 5:77 (1991)).
178. See id. at 2.
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In addition, the various risk factors that have been attributed to
the failure of partner notification efforts in controlling recent
outbreaks of syphilis - drug dependency, anonymous sex, nee-
dle-sharing partners, and the exchange of sex for drugs or
money - are all present among the fastest growing population at
risk for contracting HIV. 179
The circumstances surrounding HIV and syphilis are similar, sug-
gesting that partner notification may not effectively combat the
spread of HIV either.
III. Improving the New York Name Reporting and
Partner Notification Law
Many obstacles must be overcome before the New York Name
Reporting and Partner Notification Statute can be applied effec-
tively. Between the statute itself and the proposed regulations, a
definitive plan for instituting the law remains muddied and imprac-
tical. The following section analyzes the new law, suggesting vari-
ous changes to it while also supporting the implementation of a
unique identifier system in conjunction with partner notification.
A. Cost Efficiency of Partner Notification
Even if one assumes that the costs and resources associated with
partner notification are reasonable considering the results,18 ° one
cannot help but wonder whether available resources may be better
spent on medical research and providing access to health care. 181
"The CDC estimated in April 1987 that the cost of identifying, lo-
cating, counseling, and testing partners was $98 per HIV-infected
partner and $91 per HIV-seronegative partner. ' 18 2 New York,
however, is not just any state. One must recognize the many obsta-
179. Id. at 8.
180. See generally Andrew T. Pavia, M.D. et al., Partner Notification for Control of
HIV: Results after 2 Years of a Statewide Program in Utah, 83 AM. J. PUB. HEALTH
1418, 1422-23 (1993) ("The benefits of partner notification for HIV exposure thus
appear to outweigh the potential risks and costs, but its precise role remains to be
determined.").
181. See ACLU, Why Coercion Won't Work, supra note 119, at 12 (Data from test
sites in Florida and New Jersey show that it cost $281,964 to locate 1035 partners (of
8633 that had been named), and 122 of those notified tested positive for HIV) (citing
Thomas A. Peterman, et al., HIV Partner Notification: Cost and Effectiveness Data
from a Multicenter Randomized Controlled Trial, XI INT. CONF. AIDS, Abstract
#Th.C.4626 (1996)).
182. Dimas & Richland, supra note 43, at 206-07 (stating that the difference in cost
stemmed from the need for additional post-test counseling for HIV-positive
individuals).
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cles in reporting infected individuals and notifying their partners in
urban areas with such high seroprevalence levels such as New York
City.183
Still, New York has posited that after several thousands of dol-
lars spent on updating laboratory materials and facilities to accom-
modate the increase in HIV reporting, the additional costs
associated with reporting and notification will be nominal: $5.00
per report for a health care provider to fill out the form, $8.00 per
interview with HIV positive individual, post-test counseling that
may be eligible for Medicaid reimbursement at an average rate of
$72.00 per session, and an estimated $100.00 for one hour of time
per partner notified by a physician.'8 4 These numbers then have to
be multiplied by the additional 11,000 newly diagnosed cases of
HIV that the state expects to report annually (9000 in New York
City and 2000 in the rest of the state). 185 Also added to these costs
must be the number of contacts notified. Another factor that must
be taken into account for New York City in particular is the diffi-
culty in locating partners of IDUs and other marginalized
groups, 86 such as people without places of permanent residence.
"[T]he fastest expansion [of HIV cases in New York] is among the
state's most disenfranchised: the poor, intravenous-drug users, peo-
ple of color, gay teenagers and runaway children.' 87 These peo-
ple, if attempted to be notified, will surely increase the costs per
notification.
The state must recognize that partner notification in New York
will necessarily be more expensive and less successful than in other
states, so that a basic weighing and evaluation of each tested indi-
vidual should be done. If it appears that the contacts named by the
index patient are not able to be located without undue costs, or the
information concerning their whereabouts is not forthcoming, a
health official may not want to incur the unexpected, additional
costs. This evaluation should be done on a case-by-case analysis so
that much needed funds that could be used for treatment are not
wasted on hopeless cases.
183. See Price, supra note 39, at 478; see also Centers for Disease Control and Pre-
vention, supra note 8 and accompanying text.
184. See Regulatory Impact Statement, Notice of Proposed Rule Making, Amend-
ment of N.Y. COMP. CODES R. & REGS., tit. 10, ch. 163, at 7-10, (1999) (proposed
regulations, on file with the Fordham Urban Law Journal).
185. See id. at 6.
186. See supra notes 177-179 and accompanying text.
187. Laurie Garrett, Hidden HIV / The Search is on for People Who Don't Know
They Carry the Virus that Causes AIDS, NEWSDAY, Aug. 18, 1998, at C6.
1999] 1481
FORDHAM URBAN LAW JOURNAL [Vol. XXVI
B. A Unique Identifier System
New York could achieve its twin goals of data collection and
partner notification without discouraging testing by instituting a
unique identifier system and eliminating name reporting. 188 As
noted earlier, this system has been instituted in Maryland, and until
recently, Texas.' 89 Although Maryland recognizes its problems
with incomplete reports, it notes that the percentage of complete
reports has been steadily increasing. 190 A pilot program, whereby
staff members are trained in the unique identifier system, has re-
sulted in a markedly improved 96.6% completeness rate.1 91 There-
fore, New York should ensure that health department employees
creating unique identifier numbers undergo training programs
when the system is initiated.
A unique identifier system's success is measured by more than
the completeness of the numbers reported. Its "ability to match
the [unique identifiers] of persons listed in the UI Registry with the
UI's of persons listed in the state's AIDS Registry and conse-
quently to be able to distinguish new cases of HIV infection from
previously reported AIDS cases" also mark a system's value. 92
Maryland's match rate was 76.5%, while that of Alabama and Ari-
zona, two states using HIV name reporting, had match rates of sev-
enty-nine to ninety percent.193  The seroprevalence rate of
Maryland, however, is approximately three times higher than that
of Alabama and Arizona, suggesting a higher case load; may have
been responsible for lower match levels.' 94 Because New York has
one of the highest seroprevalence rates in the U.S., 195 a unique
identifier system is feasible within the state only with better train-
ing, adequate staffing, and more resources proportionate to its ser-
oprevalence rate. If New York can lead the way in instituting an
efficient and effective unique identifier system, it should not be dif-
ficult for other states to follow.
After a series of public meetings revealed great opposition to a
name-based reporting system, Washington authorized a pilot pro-
188. See N.Y. PUB. HEALTH LAW § 2130 (McKinney 1999).
189. See TDH, HIV Reporting by Name, supra note 126.
190. See ACLU, The Maryland Lesson, supra note 123 ("While only 61% of UI's
reported in the first six months of the program were complete, approximately 77% of
the UI's reported in the last six months of 1996 were complete.").
191. See id.
192. Id.
193. See id.
194. See id.
195. See supra note 10 and accompanying text.
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gram using a non-name unique identifier system.196 The Washing-
ton system differs slightly from those used in Texas and Maryland
and promises to eliminate incomplete reports and assure confiden-
tiality by destroying records linking the individual to her identi-
fier. 197 In this new system, the individual's name and related
information would be sent to the health department, who would
then create the coded number and delete the individual's name
from the database, 98 rather than requiring the entity who does the
testing to complete these tasks. If the Washington system does
lead to more complete reports, New York also should tailor its pro-
gram similarly. By shifting the onus of creating coded numbers
onto the health department, the state does not need to rely on the
cooperation of private facilities, especially if cooperation is not
forthcoming.
Rather than employing the twelve digit number used in Mary-
land,199 New York should expand its system to include important
information such as risk behavior.2 °° This goal can be accom-
plished by encoding different behaviors and adding more digits to
the system. The addition of risk behavior and other information
may assist in locating trends among certain at-risk populations or
identifying other populations that are increasingly affected by the
epidemic, so as to maximize the infusion of resources where they
are needed most.
C. Non-cooperation by the Index Patient
As required by the New York Bill, the report sent to the com-
missioner at the state health department will contain information
identifying both the index patient and any contacts. 20 1 The first
obvious problem with this law and other partner notification stat-
utes is the hurdle posed by an index patient's refusal to cooperate
with the authorities. Although the index patient may be forced to
reveal her own name to obtain insurance reimbursement,2 2 she
196. See Washington State Moves Toward Study of Unique Identifiers, AIDS POL'Y
& L., Mar. 6, 1998, at 12.
197. See id.
198. See id.
199. See supra note 123 and accompanying text.
200. See generally CDC, Evaluation of HIV Case Surveillance, supra note 124, at
1254 (noting the importance of including HIV risk information for an effective sur-
veillance system).
201. See N.Y. PUB. HEALTH LAW § 2130(3) (McKinney 1999).
202. See Notice of Proposed Rule Making, Amendment of N.Y. COMP. CODES R.
& REcS., tit. 10, §§ 63.2-63.3(a)(1) (1999) (proposed regulations, on file with the
Fordham Urban Law Journal) ("[F]or purpose of insurance coverage, confidential, as
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cannot be forced to reveal the name of her sexual and/or needle-
sharing contacts. The law stipulates that no criminal or civil liabil-
ity will result for any index patient's failure to cooperate in contact
tracing. °3
This non-cooperation obstacle suggests that the process of part-
ner notification, at its essence, is voluntary or contingent on index
patient cooperation. That is not to say that coercive notification
may not occur. An individual ignorant of her rights under the law
may be unwillingly duped into cooperation. Even worse, she may
lie about her sexual history and characteristics, resulting in inaccu-
rate data. Thus, written informed consent20 4 is the key to managing
non-cooperation. Informed consent for HIV testing here means
that the patient who is to be tested must first be given pre-test
counseling, which includes explanations regarding the nature of the
disease and current treatment options, the possibility of discrimina-
tion, and ways to prevent transmission.2 °5 Most importantly, how-
ever, pre-test counseling includes notice of name reporting and
partner notification, and the availability of anonymous testing
sites.2 °6
In addition to these elements of informed consent, health offi-
cials and physicians should be required to inform patients of their
right not to disclose contacts, while always emphasizing the impor-
tance of contacting partners. This Miranda-like20 7 warning should
be built into the informed consent definition such that a failure to
give it to the individual about to undergo testing may result in pro-
fessional liability for the physician or center offering the test.
opposed to anonymous testing is required."). The reporting regulations apply to peo-
ple receiving confidential HIV-related information.
203 See N.Y. PUB. HEALTH LAW § 2136(3) (McKinney 1999).
204. See id. § 2780(5). "Capacity to consent" is defined as:
an individual's ability, determined without regard to the individual's age, to un-
derstand and appreciate the nature and consequences of a proposed health care
service, treatment, or procedure, or of a proposed disclosure of confidential HIV-
related information, as the case may be, and to make an informed decision con-
cerning the service, treatment, procedure or disclosure.
Id.
205. See id. § 2781(3).
206. See id. § 2781(4).
207. In Miranda v. Arizona, 384 U.S. 436 (1966), the Supreme Court held that
statements that were obtained from defendants during incommunicado interrogation
in a police-dominated atmosphere, without full warning of constitutional rights, were
inadmissible as having been obtained in violation of the Fifth Amendment privilege
against self-incrimination.
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D. Defining "Contacts"
This problem of non-cooperation, in turn, creates another one:
the problem of defining the term "contact." The amendments to
section 2780(10) attempt to elaborate on the definition of
"contact":
identified spouse or sex partner of the protected individual, a
person identified as having shared hypodermic needles or syr-
inges with the protected individual or a person who the pro-
tected individual may have exposed to HIV under circumstances
that present a risk of transmission of HIV, as determined by the
commissioner.2 0o
This definition is neither exhaustive nor realistic. It does not take
into account the existence of sexually-inactive spouses or estranged
spouses, nor does it clearly delineate how far back the contact trac-
ing process must venture. It also does not set limits on the extent
of probing a health official or physician must undertake, such as
whether she must investigate claims of sexual inactivity by the in-
dex patient. The law's over-broad reach may extend into the realm
of marital privacy, an area upon which the Supreme Court has de-
clined to tread.20 9 Infringement on the privacy rights of one's sex-
ual partners also is prohibited.21 0
E. Notification of Contacts
"[T]he municipal health commissioner or the department's con-
tact notification assistance program staff ... [must make a] deter-
mination that the reported case or any other case merits contact
notification in order to protect the public health .... ,211 Factors to
be considered in this determination are the awareness of known
contacts and situations involving newly-diagnosed persons with
HIV.212 The first factor is obviously spawned out of convenience;
limited or no investigation is required prior to notification. The
second factor, on the other hand, does not seem grounded in any
logic. What the health official may think is a "new diagnosis" may
actually be a "newly discovered" one because of the difficulty in
208. N.Y. PuB. HEALTH LAW § 2780(10) (McKinney 1999).
209. See generally Griswold v. Connecticut, 381 U.S. 479 (1965) (recognizing a zone
of privacy in the marital realm).
210. See generally Eisenstadt v. Baird, 405 U.S. 438 (1972) (extending the privacy
rights of married couples to unmarried couples under the Equal Protection Clause).
211. Notice of Proposed Rule Making, Amendment of N.Y. COMP. CODES R. &
REGS., tit. 10, § 63.8(a)(3) (1999) (proposed regulations, on file with the Fordham
Urban Law Journal).
212. See id. § 63.8(b).
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predicting with certainty when a person first contracted the dis-
ease. Also, it would seem more efficacious to notify partners of
someone who has been HIV positive for a longer period because
there has been a longer period in which the person has been
infectious.
The New York law also requires health officials to notify the con-
tact in person unless circumstances prevent this method.213 While
the great expense of carrying out this requirement exhausts money
and resources that could be used in finding a cure or better treat-
ments,214 the in-person notification may be well worth the expense
in such an emotionally-charged situation. Moreover, providing the
contact with an opportunity to receive detailed advice on the im-
portance of getting tested and reducing risk behavior from an indi-
vidual trained to share accurate information is critical. After all,
partner notification serves little purpose in breaking the chain of
transmission if the notified individual does not then herself get
tested.
Many opponents of the law understandably fear health officials
knocking on a contact's door while neighbors look on or leaving a
message that the contact should get in touch with the local health
department. Thus, the state should consider a policy of notifying
contacts in neutral places, such as the physician's office or the local
health department. If telephone contact must be made, the health
official should never leave a message with a party other than the
named contact.
F. Special Cases Where Immunity Should be Granted
During the notification process, the commissioner or authorized
official is not permitted to divulge the identity of the index patient
or the identity of any other contact.21 5 In reality, the identity pro-
tection offered by the plan is a fagade in some circumstances where
the index patient's identity easily can be deduced. For example, if
the contact of an index patient only has engaged in sexual relations
with the index patient and has never injected drugs, the identity of
the index patient may be obvious to the contact. Under these cir-
213. See N.Y. PuB. HEALTH LAW § 2133(4) (McKinney 1999).
214. See supra notes 182-155 and accompanying text.
215. See N.Y. PuB. HEALTH LAW § 2133(3) (McKinney 1999); see also Notice of
Proposed Rule Making, Amendment of N.Y. COMP. CODES R. & REGS., tit. 10, § 63.1
(1999) (proposed regulations, on file with the Fordham Urban Law Journal) ("In all
cases of contact tracing authorized in this Part, the name or other identifying informa-
tion regarding the protected person shall not be disclosed to contacts and the name of
contacts shall not be disclosed to other contacts.").
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cumstances, the statute should have an immunity provision, which
weighs the degree of exposure to the contact against the need for
confidentiality to the index patient on a case-by-case basis. Unless
the degree of risk is substantially likely to transmit the virus, immu-
nity should be granted to the index for nondisclosure. Of course,
the index patient should always be strongly encouraged to notify
on her own, despite the risk of discovery.
Another difficult scenario for partner notification proceedings is
where domestic violence plays a role. Physicians and other persons
required to report must indicate whether they have conducted a
domestic violence screen on each case.216 Statistics show that do-
mestic violence in relationships is prevalent,217 and partner notifi-
cation to an abusive spouse may aggravate the situation. As part of
the aforementioned HIV "Miranda" warning, the health authority
should initiate the inquiry into whether there exists a threat of do-
mestic violence for the individual being tested, rather than waiting
for the patient to offer the evidence him/herself. The health official
also should clearly explain that the threat of domestic violence may
excuse the patient from partner notification.218
Additionally, considering the difficulty in detecting domestic vio-
lence and the secrecy usually maintained around it by victims, the
state may want to defer domestic violence judgments to those pro-
fessionally-trained in such matters, rather than give just any physi-
cian or authorized testing facility such important discretionary
power. In the alternative, the state should train health officials in
domestic violence screening, and then defer to their discretionary
power.
G. The Physician's Role
Another problem associated with New York's law is the unwar-
ranted emphasis it places on the doctor-patient relationship,
presuming that there exists something inherently special between
216. See Notice of Proposed Rule Making, Amendment of N.Y. COMP. CODES R.
& REGS., tit. 10, § 63.8 (a)(1) (1999) (proposed regulations, on file with the Fordham
Urban Law Journal).
217. See supra notes 155-156 and accompanying text.
218. See Notice of Proposed Rule Making, Amendment of N.Y. COMP. CODES R.
& REGS., tit. 10, § 63.8(c) (1999) (proposed regulations, on file with the Fordham
Urban Law Journal) ("Where partner notification is otherwise merited, "if an indica-
tion of risk of domestic violence has been identified, the health official must be satis-
fied in his/her professional judgment that reasonable arrangements and referrals to
address safety of affected persons have been made if and when the notification is to
proceed.").
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provider and patient to warrant disclosure by that particular pro-
vider, as opposed to any other. By assigning such highly personal
responsibilities to physicians, the state may be relying upon a mis-
perception of the status of the professional relationship as it exists
currently. In today's managed care system, it is not uncommon for
an individual to lack a close relationship with her physician.219 In
fact, with the relatively recent advent of health care maintenance
organizations and preferred provider organizations, a patient may
see a different healthcare provider with every visit. The days of the
family doctor that cared for the patient from birth on is no longer a
reality for most individuals.
Also, the law does not explore the ramifications of disclosure
from the contact's perspective. Although the index patient may
have established a relationship with the physician, it is unlikely that
the contact also would know the physician. Mandating that the in-
dex patient disclose her risk practices with others, the law also
reveals risk practices of the contact, including sexual and/or drug-
related activity that the contact may want to keep confidential.
Despite confidentiality requirements, partner notification may in-
fringe on the contact's right to privacy and confidentiality.
220
The law addresses the issue of possible liability incurred by the
reporting individual or agency: "Good faith reporting or disclosure
pursuant to this title shall not constitute libel or slander or a viola-
tion of the right of privacy or privileged communication. '22' Fur-
thermore, immunity from civil and criminal liability is granted for
good faith attempts at reporting.222 This provision is essential to
eliminating any kind of fear a physician might feel concerning legal
action.
The amendment also changes section 2782(4) of the Public
Health Law, concerning the physician's authorization to notify con-
tacts: "A physician may disclose confidential HIV related informa-
tion ... [if] the physician has counseled the protected individual
[about notification] . . . and . . . the physician has informed the
protected individual of his or her intent to make such disclosure to
a contact .... 223 In this instance, the physician must give the
219. See BARRY R. FURROW ET AL., HEALTH LAW ch. 3.111, at 800 (3d ed. 1997)
(arguing that "[b]ecause subscribing to an HMO usually means being treated by an
HMO-affiliated doctor, HMOs are less likely to attract persons with chronic illnesses
already attached to a doctor").
220. See supra notes 147-149 and accompanying text.
221. N.Y. PUB. HEALTH LAW § 2136(1) (McKinney 1999).
222. See id. § 2136(2).
223. Id. §§ 2782(4)(a)(3)-(4)(a)(4).
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index patient an opportunity to express a preference as to the pro-
cess of disclosure.224
In the patient referral model, it may be difficult for health au-
thorities to ensure that contacts have been notified. Also, fewer
partners may be notified in this model in comparison to the physi-
cian referral model.225 Unfortunately, if the goal of partner notifi-
cation is to actually notify contacts, New York's provision giving
index patients an option over whether to personally inform con-
tacts or assign that responsibility to a health authority may be self-
defeating. Thus, it is important that the law requires public health
officers to take reasonable steps to inform contacts if notification
by the physician cannot be verified.226 In a unique identifier sys-
tem, however, the contact may even use a code name for herself
that has been prearranged, and/or refer to the index patient
through her unique identifier number.
H. Anonymous Testing Sites
Despite the enactment of the new law, anonymous testing sites
still are alternatives to confidential testing, which will be accompa-
nied by name reporting.227 Currently, the availability of anony-
mous testing is important because even with a system of non-
named reporting in place, some individuals will fear confidentiality
breaches. Although anonymous testing may create some initial
data errors,228 it may be the only way to encourage certain groups
to be tested and possibly conduct partner notification.
A multistate survey found benefits to anonymous testing, such as
a shorter time span between being tested anonymously and seeking
treatment than that of testing confidentially and entering the
healthcare system: "The mean time from learning they were HIV
positive to the diagnosis of AIDS was almost a year and a half
longer (529 days) for those tested anonymously than for those
224. See id. § 2782(a)(4).
225. See supra note 51 and accompanying text.
226. See Notice of Proposed Rule Making, Amendment of N.Y. COMP. CODES R.
& REGS., tit. 10, § 63.80)(4) (1999) (proposed regulations, on file with the Fordham
Urban Law Journal).
227. See N.Y. PUB. HEALTH LAW § 2138 (McKinney 1999). The option of anony-
mous testing may be more mirage than real under the revised law since a patient must
be tested confidentially in order to receive insurance reimbursement for HIV medical
treatment. See supra note 202 and accompanying text.
228. See Bindman et al., supra note 96, at 1416 ("Because people who test HIV
positive anonymously cannot be individually identified, reporting systems that rely on
the results of anonymous testing are prone to measurement error. It can be difficult
to detect repeat tests, and the potential exists for duplicate reporting.").
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tested confidentially . "..."229 Earlier testing allowed patients to
receive the benefits of a longer period of medical treatment for
HIV.23 ° The same survey also showed that almost a quarter of
HIV-positive persons who had been tested voluntarily before being
diagnosed with AIDS had sought anonymous testing.23 a Thus, at
least for the present, the option of anonymous testing is crucial in
New York because it may alleviate many of the fears associated
with HIV testing.
Eventually, however, anonymous testing should be phased-out
to prevent data errors, which threaten to be substantial: "Anony-
mous testing appears to be on the upswing in New York. In 1992,
nearly 190,000 New Yorkers had an HIV test in a publicly funded
facility. In 1996, that number was less than 40,000. ' '232 These sta-
tistics can only mean either New Yorkers have switched to private,
anonymous testing or there has been a seventy-nine percent de-
crease in HIV testing.233 Once people are made to understand the
privacy protections of a unique identifier system, the elimination of
anonymous testing should not be so frightening. The unique iden-
tifier system would alleviate most confidentiality fears while still
maintaining accurate and comprehensive data.
Conclusion
The world soon will be entering the third decade of the HIV/
AIDS epidemic. Despite great advances in treatment, there is no
cure and AIDS remains an ultimately fatal disease. The New York
legislature's passage of a HIV name reporting and partner notifica-
tion law marks a monumental step in the history of the disease
because of the state's high seroprevalence level.2 34 Despite the
lofty goals set by advocates of partner notification,such as inform-
ing those who have been exposed to HIV with the hope that they
will then be tested and motivated into less risky behavior,235 draw-
backs still exist. The fear of stigmatization is still strong, as is the
possibility of discrimination.236 There is no doubt that some peo-
ple, whether few or many, will be deterred from being tested. 37
229. Id. at 1418.
230. See id.
231. See id.
232. Garrett, supra note 187, at C6.
233. See id.
234. See supra note 10 and accompanying text.
235. See supra note 168 and accompanying text.
236. See supra notes 161-167 and accompanying text.
237. See supra notes 168-169 and accompanying text.
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In order to achieve the twin goals of the collection of epidemio-
logical data for research purposes and the notification of partners
exposed to risk, the New York law needs to be modified. By re-
placing name reporting with a more refined system of unique iden-
tifiers, which include valuable factors like risk behavior, the first
goal may be achieved and patient security ensured. Modifying the
New York statute to include immunity provisions for certain pa-
tients and opt-out provisions for providers may also further these
goals. In the end, it appears that a unique identifier system in con-
junction with a compassionate system of partner notification may
be the best route for New York to take in its fight against AIDS.
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